Validation of the Beneware model ABP-021 ambulatory blood pressure monitor according to the revised 2010 European Society of hypertension international protocol.

08:00 EDT 11th June 2018 | BioPortfolio

Summary of "Validation of the Beneware model ABP-021 ambulatory blood pressure monitor according to the revised 2010 European Society of hypertension international protocol."

This study aimed to evaluate the accuracy of the Beneware model ABP-021 oscillometric blood pressure monitor in the general population according to the European Society of Hypertension International Protocol (ESH-IP). The accuracy of the device was assessed in relation to various clinical variables, including age, sex, BMI, and arm circumference.


Journal Details

This article was published in the following journal.

Name: Blood pressure monitoring
ISSN: 1473-5725


DeepDyve research library

PubMed Articles [20815 Associated PubMed Articles listed on BioPortfolio]

Home blood pressure monitoring in pediatric hypertension: the US perspective and a plan for action.

The 2017 US guidelines for pediatric hypertension place considerable emphasis on blood pressure measurements, which are the cornerstone for hypertension diagnosis and management. It is recognized that...

Ten-year changes in ambulatory blood pressure: The prognostic value of ambulatory pulse pressure.

Blood pressure (BP) changes and risk factors associated with pulse pressure (PP) increase in elderly people have rarely been studied using ambulatory blood pressure monitoring (ABPM). The aim is to ev...

Ambulatory blood pressure variability increases over a 19-year follow-up in a clinic on a solitary island.

This study investigated the changes of ambulatory blood pressure (ABP) profiles on the same participants over a 19-year follow-up.

Response to discussion about blood pressure monitor validation studies.

Reporting of blood pressure monitor validation studies.

Clinical Trials [12267 Associated Clinical Trials listed on BioPortfolio]

Ambulatory Blood Pressure Monitoring in Rivaroxaban Therapy

One in ten patients on rivaroxaban therapy have dizziness and reductions in blood pressure. The investigators intend to monitor the ambulatory blood pressure of such patients in order to a...

CareTaker Self-Calibration Validation

The goal of the study is to test the capability of the CareTaker monitor to calibrate its continuous blood pressure readings independently. Currently the device requires another approved b...

Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction

Children with unilateral congenital urine flow impairment, who require surgery, have abnormal 24-hour ambulatory blood pressure measurements.

Validation of Pulse Waveform Analysis-based Continuous Noninvasive Blood Pressure Measurement Sensor

The study aims to define the sensitivity and specificity of a novel continuous noninvasive blood pressure monitor.

A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"

24 hour ambulatory blood pressure (ABP) monitoring should be the first choice for diagnosis and treatment of hypertension according to European Societyof Hypertension (ESH) and the Europea...

Medical and Biotech [MESH] Definitions

Method in which repeated blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of HYPERTENSION, and can assess the effectiveness of antihypertensive therapy.

A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke.

Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.


Quick Search


DeepDyve research library

Relevant Topic

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...

Searches Linking to this Article